Orikine Bio
SpainEntry
2023
Hold
3yr
Status
Active
Who owns Orikine Bio?
Orikine Bio is a Spanish Biotech company, currently owned by AdBio Partners since 2026 and Asabys Partners.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Asabys PartnersSabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQSpain
SectorBiotech
Ownership history
2 ownership periods
Active
Asabys PartnersActive
2023 · present(3yr) · Sabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
AdBio PartnersActive
2026 · present(<1yr) · AFB Fund II · 2021 · VC
More from Sabadell Asabys Health Innovation Investments II
Other portfolio companies in the same fund.
France
BelgiumMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Orikine Bio?
Orikine Bio is currently owned by AdBio Partners and Asabys Partners, through Sabadell Asabys Health Innovation Investments II, since 2026.
When did AdBio Partners and 1 other acquire Orikine Bio?
AdBio Partners and 1 other acquired Orikine Bio in 2026.
Who has owned Orikine Bio over time?
Orikine Bio has been through 2 private-equity ownership periods: Asabys Partners · via Sabadell Asabys Health Innovation Investments II · since 2023; AdBio Partners · via AFB Fund II · since 2026.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue